Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO).

COVID-19 / prevention & control COVID-19 Vaccines Humans Inpatients Randomized Controlled Trials as Topic Vaccination / methods

Journal

Med (New York, N.Y.)
ISSN: 2666-6340
Titre abrégé: Med
Pays: United States
ID NLM: 101769215

Informations de publication

Date de publication:
12 08 2022
Historique:
received: 30 06 2022
revised: 07 07 2022
accepted: 15 07 2022
entrez: 13 8 2022
pubmed: 14 8 2022
medline: 17 8 2022
Statut: ppublish

Résumé

The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, difficulties with vaccine availability, vaccine hesitancy, and a constantly evolving virus.

Identifiants

DOI: 10.1016/j.medj.2022.07.003 PMID: 35963234 PMC: PMC9373164
pubmed: 35963234
pii: S2666-6340(22)00313-0
doi: 10.1016/j.medj.2022.07.003
pmc: PMC9373164
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

531-537

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL088942
Pays : United States
Organisme : Medical Research Council
ID : MRC_UU_12023/23
Pays : United Kingdom

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests D.L.B is on the advisory boards of Gilead, MerckSharpe & Dohme, Pfizer, and ViiV, and receives travel grants from ViiV Healthcare. G.M. receives research grants from Gilead, AbbvieInc., ViiV Healthcare, and Janssen, and is on the advisory boards of Gileadand AstraZeneca. The other authors declare no competing interests.

Références

N Engl J Med. 2022 Mar 31;386(13):1221-1229
pubmed: 35172072
Lancet. 2022 Mar 5;399(10328):924-944
pubmed: 35202601
N Engl J Med. 2022 Nov 10;387(19):1770-1782
pubmed: 36286260
Immunity. 2022 Jul 12;55(7):1316-1326.e4
pubmed: 35690062
Nature. 2022 Jul;607(7918):351-355
pubmed: 35584773
Lancet Microbe. 2022 Dec;3(12):e944-e955
pubmed: 36375482
Nat Commun. 2021 Oct 29;12(1):6250
pubmed: 34716320
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Lancet. 2022 Apr 2;399(10332):1303-1312
pubmed: 35305296
Nature. 2022 Aug;608(7923):603-608
pubmed: 35790190
N Engl J Med. 2022 Jul 7;387(1):86-88
pubmed: 35731894
Signal Transduct Target Ther. 2022 Apr 9;7(1):119
pubmed: 35397623
JAMA Netw Open. 2021 Oct 1;4(10):e2128391
pubmed: 34613401
MMWR Morb Mortal Wkly Rep. 2022 Apr 29;71(17):606-608
pubmed: 35482574

Auteurs

Eleftherios Mylonakis (E)

Division of Infectious Diseases, Rhode Island Hospital & The Miriam Hospital, Alpert Medical School of Brown University, Providence, RI, USA. Electronic address: eleftherios_mylonakis@brown.edu.

Joseph Lutaakome (J)

MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.

Mamta K Jain (MK)

U.T. Southwestern Medical Center and Parkland Health and Hospital Systems, Dallas, TX, USA.

Angela J Rogers (AJ)

Pulmonary, Allergy and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA, USA.

José Moltó (J)

Lluita contra la Sida Foundation & Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.

Susana Benet (S)

Lluita contra la Sida Foundation & Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Ahmad Mourad (A)

Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA.

D Clark Files (DC)

Division of Pulmonary, Critical Care, Allergy and Immunology, Department of Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC.

Henry Mugerwa (H)

Joint Clinical Research Centre, Lubowa and Gulu Regional Referral Hospital, Gulu, Uganda.

Cissy Kityo (C)

Joint Clinical Research Centre, Lubowa, Uganda.

Francis Kiweewa (F)

Makerere University Lung Institute (MLI), Kampala, Uganda; Lira Regional Referral Hospital, Lira, Uganda.

Mary Grace Nalubega (MG)

Lira Regional Referral Hospital, Lira, Uganda.

Jonathan Kitonsa (J)

Masaka Regional Referral Hospital, Masaka, Uganda.

Evelyn Nabenkema (E)

St Francis Hospital, Nsambya, Uganda.

Daniel D Murray (DD)

CHIP Center of Excellence for Health, Immunity, and Infections and Department of Infectious Diseases, Rigshospitalet; Copenhagen, Denmark.

Dominique Braun (D)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and Institute of Medical Virology, University of Zurich, Zurich Switzerland University Hospital Zurich, Zurich, Switzerland.

Dena Kamel (D)

UT Southwestern Medical Center, Internal Medicine, Infectious Diseases, Dallas, TX, USA.

Elizabeth S Higgs (ES)

National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.

Timothy J Hatlen (TJ)

Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.

Virginia L Kan (VL)

Infectious Diseases Section, VA Medical Center, Washington, DC, USA.

Adriana Sanchez (A)

Washington DC VA Medical Center Washington, DC, USA.

John Tierney (J)

Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.

Eileen Denner (E)

University of Minnesota, MN, USA.

Deborah Wentworth (D)

University of Minnesota, MN, USA.

Abdel G Babiker (AG)

The Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK.

Victoria J Davey (VJ)

United States Department of Veterans Affairs; Washington, DC, USA.

Annetine C Gelijns (AC)

Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Gail V Matthews (GV)

The Kirby Institute, University of New South Wales, Sydney, Australia.

B Taylor Thompson (BT)

Division of Pulmonary and Critical Care, Department of Medicine, Massachusetts General Hospital and Harvard Medical School; Boston, Massachusetts, USA.

H Clifford Lane (HC)

National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.

James D Neaton (JD)

Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.

Jens D Lundgren (JD)

CHIP Center of Excellence for Health, Immunity, and Infections and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Lessons from an international trial evaluating...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins contre la COVID-19 › Lessons from an international trial evaluating...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Lessons from an international trial evaluating...
questionsmedicales.fr › Personnes › Patients › Patients hospitalisés › Lessons from an international trial evaluating...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Essais cliniques comme sujet › Essais cliniques contrôlés comme sujet › Essais contrôlés randomisés comme sujet › Lessons from an international trial evaluating...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Vaccination › Lessons from an international trial evaluating...